Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
152.21
+2.21 (1.47%)
At close: Jan 3, 2025, 4:00 PM
152.99
+0.78 (0.51%)
After-hours: Jan 3, 2025, 4:13 PM EST
Biogen Stock Forecast
Stock Price Forecast
The 24 analysts with 12-month price forecasts for Biogen stock have an average target of 240.71, with a low estimate of 138 and a high estimate of 342. The average target predicts an increase of 58.14% from the current stock price of 152.21.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock from 26 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 7 | 6 | 6 |
| Buy | 10 | 10 | 8 | 8 | 7 | 6 |
| Hold | 6 | 6 | 8 | 10 | 13 | 14 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 24 | 25 | 26 | 26 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $315 → $138 | Buy → Hold | Downgrades | $315 → $138 | -9.34% | Jan 2, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $230 → $164 | Buy → Hold | Downgrades | $230 → $164 | +7.75% | Dec 20, 2024 |
| B of A Securities | B of A Securities | Hold Initiates $178 | Hold | Initiates | $178 | +16.94% | Dec 10, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $250 → $180 | Strong Buy → Hold | Downgrades | $250 → $180 | +18.26% | Dec 9, 2024 |
| Mizuho | Mizuho | Buy Maintains $251 → $207 | Buy | Maintains | $251 → $207 | +36.00% | Nov 21, 2024 |
Financial Forecast
Revenue This Year
9.83B
from 9.84B
Decreased by -0.04%
Revenue Next Year
9.73B
from 9.83B
Decreased by -1.09%
EPS This Year
16.71
from 7.97
Increased by 109.72%
EPS Next Year
17.06
from 16.71
Increased by 2.06%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.2B | 11.0B | 11.4B | |||
| Avg | 9.8B | 9.7B | 9.9B | |||
| Low | 9.3B | 8.6B | 8.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 4.1% | 11.9% | 17.0% | |||
| Avg | -0.0% | -1.1% | 2.2% | |||
| Low | -5.8% | -12.8% | -11.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 17.51 | 21.15 | 21.83 | |||
| Avg | 16.71 | 17.06 | 18.14 | |||
| Low | 15.82 | 14.24 | 14.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 119.7% | 26.5% | 28.0% | |||
| Avg | 109.7% | 2.1% | 6.4% | |||
| Low | 98.5% | -14.8% | -17.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.